ARVN
insider transactionsARVINAS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-100.3K
20.0K buy · 120.3K sell
Net value · 365d
-$1.1M
$268.1K in · $1.4M out
Sentiment · 365d
Net selling
16% buying · 84% selling
Open-market trades · 365d
22
20.0K buy · 120.3K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Chief Scientific Officer · 10b5-1
$19.6K
2.6K sh · $7.60
Own -1%
-
Sell·S
Randy Teel KEY
President and CEO
$20.0K
2.2K sh · $9.04
Own -1%
-
Sell·S
Andrew Saik KEY
Chief Financial Officer
$110.7K
11.1K sh · $9.94
Own -5%
-
Sell·S
VP, Chief Accounting Officer
$19.1K
1.9K sh · $9.94
Own -5%
-
Sell·S
Chief Scientific Officer
$96.0K
9.7K sh · $9.94
Own -5%
-
Sell·S
Chief Medical Officer
$110.4K
11.1K sh · $9.94
Own -5%
-
Sell·S
Randy Teel KEY
President and CEO
$96.0K
9.7K sh · $9.94
Own -3%
-
Sell·S
Chief Medical Officer
$71.4K
6.4K sh · $11.10
Own -3%
-
Buy·P
Director
$268.1K
20.0K sh · $13.40
Own +26%
-
Sell·S
Director
$154.9K
11.8K sh · $13.14
Own -1%
-
Sell·S
Director
$249.2K
18.8K sh · $13.24
Own -2%
-
Sell·S
Director
$62.1K
4.7K sh · $13.24
Own -0%
-
Grant·A
VP, Chief Accounting Officer
$0
18.5K sh
Own New
-
Grant·A
VP, Chief Accounting Officer
$0
12.4K sh
Own +42%
-
Grant·A
Chief Scientific Officer
$0
67.0K sh
Own New
-
Grant·A
Chief Scientific Officer
$0
45.0K sh
Own +30%
-
Grant·A
Chief Medical Officer
$0
67.0K sh
Own New
-
Grant·A
Chief Medical Officer
$0
45.0K sh
Own +27%
-
Grant·A
Andrew Saik KEY
Chief Financial Officer
$0
67.0K sh
Own New
-
Grant·A
Andrew Saik KEY
Chief Financial Officer
$0
45.0K sh
Own +28%
-
Grant·A
Randy Teel KEY
President and CEO
$0
218.7K sh
Own New
-
Grant·A
Randy Teel KEY
President and CEO
$0
147.8K sh
Own +99%
-
Grant·A
Randy Teel KEY
President and CEO
$0
147.2K sh
Own +98%
-
Sell·S
Chief Accounting Officer
$13.5K
1.1K sh · $12.16
Own -4%
-
Sell·S
Chief Scientific Officer
$31.3K
2.6K sh · $12.16
Own -2%
-
Sell·S
Chief Scientific Officer
$12.6K
1.0K sh · $12.16
Own -1%
-
Sell·S
Randy Teel KEY
President and CEO
$45.6K
3.7K sh · $12.16
Own -2%
-
Sell·S
Randy Teel KEY
President and CEO
$12.6K
1.0K sh · $12.16
Own -1%
-
Sell·S
Randy Teel KEY
President and CEO
$52.4K
4.4K sh · $11.89
Own -3%
-
Sell·S
Andrew Saik KEY
Chief Financial Officer
$61.0K
5.1K sh · $11.89
Own -3%
-
Sell·S
Chief Scientific Officer
$54.6K
4.6K sh · $11.89
Own -3%
-
Sell·S
Chief Medical Officer
$67.6K
5.7K sh · $11.89
Own -3%
-
Sell·S
Chief Accounting Officer
$12.1K
1.0K sh · $11.89
Own -3%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Angela M Cacace 10b5-1 | Sell S | 2.6K | $19.6K |
| May 21, 2026 | Randy Teel KEY | Sell S | 2.2K | $20.0K |
| May 11, 2026 | Andrew Saik KEY | Sell S | 11.1K | $110.7K |
| May 11, 2026 | David K Loomis | Sell S | 1.9K | $19.1K |
| May 11, 2026 | Angela M Cacace | Sell S | 9.7K | $96.0K |
| May 11, 2026 | Noah Berkowitz | Sell S | 11.1K | $110.4K |
| May 11, 2026 | Randy Teel KEY | Sell S | 9.7K | $96.0K |
| Mar 18, 2026 | Noah Berkowitz | Sell S | 6.4K | $71.4K |
| Mar 6, 2026 | Briggs Morrison | Buy P | 20.0K | $268.1K |
| Feb 27, 2026 | John G Houston | Sell S | 11.8K | $154.9K |
| Feb 27, 2026 | John G Houston | Sell S | 18.8K | $249.2K |
| Feb 27, 2026 | John G Houston | Sell S | 4.7K | $62.1K |
| Feb 26, 2026 | David K Loomis | Grant A | 18.5K | $0 |
| Feb 26, 2026 | David K Loomis | Grant A | 12.4K | $0 |
| Feb 26, 2026 | Angela M Cacace | Grant A | 67.0K | $0 |
| Feb 26, 2026 | Angela M Cacace | Grant A | 45.0K | $0 |
| Feb 26, 2026 | Noah Berkowitz | Grant A | 67.0K | $0 |
| Feb 26, 2026 | Noah Berkowitz | Grant A | 45.0K | $0 |
| Feb 26, 2026 | Andrew Saik KEY | Grant A | 67.0K | $0 |
| Feb 26, 2026 | Andrew Saik KEY | Grant A | 45.0K | $0 |
| Feb 26, 2026 | Randy Teel KEY | Grant A | 218.7K | $0 |
| Feb 26, 2026 | Randy Teel KEY | Grant A | 147.8K | $0 |
| Feb 26, 2026 | Randy Teel KEY | Grant A | 147.2K | $0 |
| Feb 23, 2026 | David K Loomis | Sell S | 1.1K | $13.5K |
| Feb 23, 2026 | Angela M Cacace | Sell S | 2.6K | $31.3K |
| Feb 23, 2026 | Angela M Cacace | Sell S | 1.0K | $12.6K |
| Feb 23, 2026 | Randy Teel KEY | Sell S | 3.7K | $45.6K |
| Feb 23, 2026 | Randy Teel KEY | Sell S | 1.0K | $12.6K |
| Feb 13, 2026 | Randy Teel KEY | Sell S | 4.4K | $52.4K |
| Feb 13, 2026 | Andrew Saik KEY | Sell S | 5.1K | $61.0K |
| Feb 13, 2026 | Angela M Cacace | Sell S | 4.6K | $54.6K |
| Feb 13, 2026 | Noah Berkowitz | Sell S | 5.7K | $67.6K |
| Feb 13, 2026 | David K Loomis | Sell S | 1.0K | $12.1K |
About ARVN insider trading
This page tracks insider transactions for ARVINAS, INC. (ARVN) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.